Most symptoms improve within 4-8 weeks as the body adjusts to therapy
The proportion of those who achieved normoglycemia was 67.9% for adults who continued obesity pharmacotherapy, 41% for adults discontinuing therapy between 3 months and 1 year, and 33.1% for adults discontinuing therapy within the first 3 months
The plateau typically reflects metabolic adaptation rather than protocol failure
Research shows improvements in exercise capacity, especially for cardio or high-intensity workouts
Semaglutide downregulates the transcription factor PPARG, thereby reducing its inhibition of the downstream molecule ACSL1, leading to increased ACSL1 expression and promoting M1 polarization, ultimately enhancing the anti-tumor effects [95]
NAION Diagnosis and Long-Term Impact NAION is typically diagnosed by an ophthalmologist or neuro-ophthalmologist through: A comprehensive eye exam Optic nerve imaging Visual field testing Review of medical history and medication use There is currently no proven treatment that can reverse optic nerve damage caused by NAION
